Requirement for NF-κB in osteoclast and B-cell development

  1. Guido Franzoso1,4,
  2. Louise Carlson1,5,
  3. Lianping Xing2,5,
  4. Ljiljana Poljak1,
  5. Elizabeth W. Shores3,
  6. Keith D. Brown1,
  7. Antonio Leonardi1,
  8. Tom Tran3,
  9. Brendan F. Boyce2, and
  10. Ulrich Siebenlist1,6
  1. 1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892 USA; 2University of Texas Health Science Center San Antonio, San Antonio, Texas 78284 USA; 3Division of Hematologic Products, Center for Biologic Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892 USA

Abstract

NF-κB is a family of related, dimeric transcription factors that are readily activated in cells by signals associated with stress or pathogens. These factors are critical to host defense, as demonstrated previously with mice deficient in individual subunits of NF-κB. We have generated mice deficient in both the p50 and p52 subunits of NF-κB to reveal critical functions that may be shared by these two highly homologous proteins. We now demonstrate that unlike the respective single knockout mice, the p50/p52 double knockout mice fail to generate mature osteoclasts and B cells, apparently because of defects that track with these lineages in adoptive transfer experiments. Furthermore, these mice present markedly impaired thymic and splenic architectures and impaired macrophage functions. The blocks in osteoclast and B-cell maturation were unexpected. Lack of mature osteoclasts caused severe osteopetrosis, a family of diseases characterized by impaired osteoclastic bone resorption. These findings now establish critical roles for NF-κB in development and expand its repertoire of roles in the physiology of differentiated hematopoietic cells.

Keywords

Footnotes

  • 4 Present address: Gwen Knapp Center for Lupus and Immunology Research and The Ben May Institute for Cancer Research, The University of Chicago, Chicago, Illinois 60637 USA.

  • 5 These authors made equally significant contributions and are listed in alphabetical order.

  • 6 Corresponding author.

  • E-MAIL US3N{at}NIH.GOV; FAX (301) 402-0070.

    • Received September 30, 1997.
    • Accepted November 4, 1997.
| Table of Contents

Life Science Alliance